Observational studyHaematologica2017

Italian real-life experience with brentuximab vedotin: results of a large observational study of 40 cases of relapsed/refractory systemic anaplastic large cell lymphoma.

Alessandro Broccoli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.